Open-source protocol X402 sees explosive growth in activity, Questflow becomes the focus of the ecosystem
According to ChainCatcher, data from the x402scan explorer shows that the open-source protocol X402, released by a certain exchange's developer platform, has experienced explosive growth in activity over the past 7 days: the number of transactions reached 163,600 (a week-on-week increase of 701.7%), transaction volume reached $140,200 (a week-on-week increase of 8,218.5%), and the number of buyers reached 31,000 (a week-on-week increase of 15,000%). The popularity of the X402 protocol has also driven a comprehensive rise in related concept tokens, making it a recent focal point in the on-chain ecosystem.
As the official partner of the X402 protocol, Questflow not only previously received official endorsement from X402, but also firmly holds the top spot in X402's transaction volume rankings among all projects except those in the Meme ecosystem.
Questflow stated that it will continue to work hand in hand with the X402 ecosystem to jointly promote innovation and development in decentralized trading and application ecosystems.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency
The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
